ROX Medical Raises $6M to Start Trials of Hypertension Procedure
September 10, 2012
ROX Medical has closed on $6 million in venture funding. Investors in the latest round include continuing investors Domain Associates and Versant Ventures. The capital will be used to initiate an international trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure).